on 17 Jan 2025
Last Applicant/ Owned by
Novartis AG
CH-4002 Basel
CH
Serial Number
2266647 filed on 22nd May 2023
Registration Number
TMA1285034 registered on 17th Jan 2025
Registration expiry Date
22nd May 2033Trademark usage description
préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les m Read More12
2266647
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 42 on 30th Oct 2024 | Advertised |
Submitted for opposition 26 on 3rd Oct 2024 | Approved |
Submitted for opposition 27 on 3rd Oct 2024 | Approval Notice Sent |
Submitted for opposition 22 on 24th Sept 2024 | Search Recorded |
Submitted for opposition 256 on 29th Apr 2024 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 29th Jun 2023 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 28th Jun 2023 | Created |
Submitted for opposition 31 on 28th Jun 2023 | Formalized |
Submitted for opposition 228 on 22nd May 2023 | International Registration |
Submitted for opposition 30 on 22nd May 2023 | Filed |